Join
Live feed
·
INSIDERFilingvia Quantisnow
Actuate Therapeutics Inc. logo

President, CEO and Director Schmitt Daniel M converted options into 272,055 shares and covered exercise/tax liability with 121,874 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACTU· Actuate Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACTU (Actuate Therapeutics Inc.) and more on Quantisnow.